pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.Health ProductsAug 12th, 2026 @ 12:00 PM
Basic Details
Category: Health products - Drugs
Product: pms-IRBESARTAN 150 mg Tablet
Issue: Health products - Contamination
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
Products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Pharmascience Inc. | pms-IRBESARTAN | DIN 02317079 | Tablet | 150 mg | 667278 |
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.